Nanoscaled biosensors: reading epigenetic signatures to improve breast cancer diagnosis and treatment
Finish Year: 2011
Chief Investigator: Professor Matt Trau
Institution: University of Queensland
Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Alternative Title: New tools for better diagnosis of Breast Cancer
Due to limitations with current diagnostic and prognostic tools, many breast cancer patients are subjected to unnecessary adjuvant therapies, while others relapse and die despite having been treated according to state-of-the-art clinical guidelines. This situation indicates a need for a novel and innovative technology to develop clinically useful prognostic tools.
This project seeks to address this by developing nanoscaled biosensors for breast cancer.
This research is co-funded by NBCF and Cancer Australia.